Intelligence Platform

Patents

Browse 783 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed

patent

US 10166244

Targeting NCCA-ATP channel for organ protection following ischemic episode

The United States of America as represented by the Department of Veteran Affairs · Granted Tue Jan 01 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 27 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10143721

Combination product for the prevention of sexually transmitted infections

The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Tue Dec 04 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 29 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10137188

Cell lines for virus production and methods of use

The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Tue Nov 27 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 22 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10137136

Methods for inhibiting muscle atrophy

THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF VETERANS AFFAIRS · Granted Tue Nov 27 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 22 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10124043

Mutant OPAA enzymes with increased catalytic efficiency on organophosphorus compound EA135

The United States of America as represented by the Secretary of the Army · Granted Tue Nov 13 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 08 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10093710

Heterodimers of IL-15 and IL-15R alpha to increase thymic output and to treat lymphopenia

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Oct 09 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 04 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10092637

Dengue virus E-glycoprotein polypeptides containing mutations that eliminate immunodominan

granted patent

US 10081658

Truncated HIV envelope proteins (ENV), methods and compositions related thereto

The United States of America as represented by the Secretary of the Army · Granted Tue Sep 25 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 20 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10081659

Adeno-associated vectors for enhanced transduction and reduced immunogenicity

The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Tue Sep 25 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 20 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10081669

Therapy for filovirus infection

granted patent

US 10077446

Glucan-encapsulated siRNA for treating type 2 diabetes mellitus

The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Tue Sep 18 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 13 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10072084

Dual specific immunotoxin for brain tumor therapy

The United States of America as Represented by the Secretary Department of Health and Human Services (NIH) · Granted Tue Sep 11 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 06 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10064933

Recombinant rift valley fever (RVF) viruses and methods of use

The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · Granted Tue Sep 04 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 30 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10064858

Methods and compositions for treating bacterial infections with iron chelators

The United States of America as represented by the Secretary of the Army · Granted Tue Sep 04 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 30 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10053514

Human bispecific EGFRvIII and CD3 antibody engaging molecules

The United States of America as Represented by the Secretary of Health and Human Services, National Institutes of Health · Granted Tue Aug 21 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 16 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10052382

Methods for using antibodies for 3′ iso-LM1 and 3′, 6′-iso-LD1tumor gangliosides

The United States of America as Represented by the Secretary of Health (NIH) · Granted Tue Aug 21 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 16 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10052374

Compositions, methods and uses for dengue virus serotype-4 constructs

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Aug 21 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 16 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10039741

Use of delta tocopherol for the treatment of lysosomal storage disorders

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Aug 07 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 02 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10040830

Methods and compositions for protein delivery

The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Tue Aug 07 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 02 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10040826

Human immunodeficiency virus type 1 (HIV-1) N-terminal deleted GP120 immunogens

The United States of America as represented by the Secretary of the Army · Granted Tue Aug 07 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 02 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10034936

Method of inducing a cross-reactive HIV-1 immune response by administering a composition c

THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF VETERANS AFFAIRS · Granted Tue Jul 31 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 26 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10016480

Peptide-based methods for treating pancreatic cancer

The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Tue Jul 10 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 05 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10004800

Antibody evolution immunogens

The United States of America as Represented by The Secretary of the Department of Health and Human Services National Institutes of Health Office of Technology Transfer · Granted Tue Jun 26 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 21 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10000556

Single-domain VHH antibodies directed to norovirus GI.1 and GII.4 and their use

The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Tue Jun 19 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 14 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted